Evaluation of the correlation between antibiotic use and survival in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs).

Paz J. Vellanki,Shanthi Marur,Pradeep Bandaru,Pallavi Shruti Mishra-Kalyani,Kunthel By,Andrew Girvin,Somak Chatterjee,Harpreet Singh,Patricia Keegan,Erin A. Larkins,Frank C. Cross,Richard Pazdur,Marc Robert Theoret

Evaluation of the correlation between antibiotic use and survival in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs).

2020

Paz J. Vellanki
Shanthi Marur
Pradeep Bandaru
Pallavi Shruti Mishra-Kalyani
Kunthel By
Andrew Girvin
Somak Chatterjee
Harpreet Singh
Patricia Keegan
Erin A. Larkins
Frank C. Cross
Richard Pazdur
Marc Robert Theoret

6509Background: Recent evidence suggests that treatment with systemic antibiotics (Abx) disrupts the intestinal microbiome and may be associated with decreased survival for patients receiving treat...

Keywords:

Internal medicine
Oncology
antibiotic use
immune checkpoint inhibitors
Head and neck squamous-cell carcinoma
in patient
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations